Results 241 to 250 of about 608,438 (366)

Mercaptans in malodorants break disulfide bridges in human serum albumin and form adducts suitable as biomarkers of exposure in vitro

Drug Testing and Analysis, EarlyView.
Disulfide adducts of mercaptans with cysteine residues in human serum albumin were detected as tripeptides and dipeptides after proteolysis with proteinase K. All peptide adducts were detected simultaneously with a mass spectrometry‐based method working in the scheduled multiple reaction monitoring (sMRM) mode.
Paula Helena Sieber, Dirk Steinritz, Franz Worek, Harald John   +3 more
wiley   +1 more source

Principi zbrinjavanja ratnih povreda grudnog koša [PDF]

Vojnosanitetski Pregled, 2002
Stepić Vladislav, Stanić Vojkan, Cvijanović Vlado, Ristanović Aleksandar, Gulić Bojan   +4 more
doaj   +1 more source

Factor Structure, Internal Consistency, and Measurement Invariance of the Eating Pathology Symptoms Inventory (EPSI) in Transgender and Gender‐Diverse Adults

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective This study aimed to examine the psychometric properties, including factor structure, internal consistency, and measurement invariance of the Eating Pathology Symptoms Inventory (EPSI) in a large national sample of transgender and gender‐diverse (TGD) adults. Method The sample consisted of 2098 TGD adults—including transgender men (n =
Jason M. Nagata, Christopher D. Otmar, Audrey Lopez, Emilio J. Compte, Jason M. Lavender, Tiffany A. Brown, Kelsie T. Forbush, Annesa Flentje, Micah E. Lubensky, Juno Obedin‐Maliver, Mitchell R. Lunn   +10 more
wiley   +1 more source

The goldilocks conundrum: Disclosing discrimination risks in informed consent

Journal of Genetic Counseling, Volume 31, Issue 6, Page 1383-1393, December 2022., 2022
Abstract Informed consent is a foundational ethical and legal principle in human subjects research and clinical care. Yet, there is extensive debate over how much information must be disclosed to meet ethical goals and legal requirements, especially about non‐medical risks.
Anya E. R. Prince, Sonia M. Suter, Wendy R. Uhlmann, Aaron M. Scherer   +3 more
wiley   +1 more source

Piloting delivery of PfSPZ vaccines for malaria through a cryogenic vaccine cold chain to travel and military medicine clinics. [PDF]

J Travel Med
James ER, Church LWP, Hoffman SL, Richie TL, Robertson BD, Hickey PW, Schwartz DJ, Logan PT, Asare TD, Jones ML, Bay JL, Roschel AK, Pfeiffer JL, Acosta RW, Schiavi E, Acosta AM, Noble M, Henkel T, Young C.   +18 more
europepmc   +1 more source

Medicos, poultice wallahs and comrades in service: masculinity and military medicine in Britain during the First World War. [PDF]

Crit Mil Stud, 2019
Meyer J.
europepmc   +1 more source

Treatment outcomes and costs of a simplified antiretroviral treatment strategy for hepatitis C among Hepatitis C Virus and Human Immuno deficiency Virus co‐infected patients in Ukraine

JGH Open, Volume 6, Issue 12, Page 894-903, December 2022., 2022
We assessed treatment and cost outcomes for integrated HIV and viral hepatitis testing with ledipasvir/sofosbuvir ± weight‐based ribavirin for 12 weeks in Kyiv, Ukraine. Overall, a sustained virological response (SVR) was achieved in 831 of 868 patients (95.7%).
Sergie Antoniak, Charles S Chasela, Morgan Julie Freiman, Yulia Stopolianska, Tetiana Barnard, Malini M Gandhi, Maria Liulchuk, Zhanna Tsenilova, Tretiakov Viktor, Jeri Dible, Constance Wose Kinge, Francis Akpan, Thomas Minior, Ntombi Sigwebela, Sofiane Mohamed, Matthiue Barralon, Fadzai Marange, Clint Cavenaugh, Charles Vander Horst, Svitlana Antonyak, Thembisile Xulu, Kara W Chew, Ian Sanne, Sydney Rosen, for EQUIP Health   +24 more
wiley   +1 more source

Prospective applications of induced pluripotent stem cells in military medicine. [PDF]

Med J Armed Forces India, 2018
Saha B, Krishna Kumar H, Borgohain MP, Thummer RP.   +3 more
europepmc   +1 more source

Morning Report in Military Family Medicine Residencies [PDF]

, 2008
Erin Drifmeyer, Robert Oh
openalex   +1 more source

End‐organ protective effect of serelaxin in patients hospitalized for heart failure: Results of the biomarker substudy of Relaxin in Acute Heart Failure‐2 (RELAX‐AHF‐2)

European Journal of Heart Failure, EarlyView.
End‐organ protective effect of serelaxin in patients with acute heart failure. CV, cardiovascular; HF, heart failure; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. Abstract Aims Serelaxin is recombinant human relaxin‐2, a hormone responsible for haemodynamic adaptations and organ protection in pregnancy.
Adriaan A. Voors, Marco Metra, Douwe Postmus, Barry H. Greenberg, Gadi Cotter, Beth A. Davison, Iris E. Beldhuis, G. Michael Felker, Gerasimos Filippatos, Peter S. Pang, Piotr Ponikowski, Claudio Gimpelewicz, John R. Teerlink   +12 more
wiley   +1 more source